CHD4 is the predominant chromatin remodeling mutation in a rare and aggressive form of endometrial carcinoma known as uterine serous carcinoma, in which 17% of cases have CHD4 mutations(17, 18). This evidence concerns the gene CHD4 and endometrial serous adenocarcinoma.